RICHARD BURR
RICHARD BURR is named as a lobbyist in 18 lobbying reports we hold, filed by 1 registrant for 18 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
- U.S. Senator
Registrants and clients
- DLA PIPER LLP (US) · 18 reports
Clients: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED); ATLANTIC COAST CONFERENCE; AVALYN PHARMA INC.; BIOGEN, INC.; BIOTECHNOLOGY INNOVATION ORGANIZATION; COALITION FOR SMARTER REGULATION OF NICOTINE; CROWDSTRIKE, INC.; DSRB DEVELOPMENT GROUP; DUKE UNIVERSITY; NAPATREE TECHNOLOGY, LLC; NATIONAL EMPLOYMENT OPPORTUNITIES NETWORK; NOVARTIS; PARTICULA GROUP INC.; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; REGENXBIO INC.; UNITED WAY WORLDWIDE; UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; WAKE FOREST UNIVERSITY.
Bills named where this lobbyist is listed, and how the House and the Senate voted
13 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 3633Digital Asset Market Clarity Act | Passed the House | No recorded vote in our record |
| H.R. 4312SCORE Act | Reported by committee | No recorded vote in our record |
| H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 | Passed the House | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9495Department of Defense Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| S. 492Improve and Enhance the Work Opportunity Tax Credit Act | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 2932Student Athlete Fairness and Enforcement Act | Introduced | No recorded vote in our record |
| S. 4668Protect College Sports Act of 2026 | Passed the Senate | No recorded vote in our record |
| S. 4784National Defense Authorization Act for Fiscal Year 2027 | Reported by committee | No recorded vote in our record |
Issues named: Health Issues (8), Medical/Disease Research/Clinical Labs (5), Medicare/Medicaid (4), Taxation/Internal Revenue Code (4), Copyright/Patent/Trademark (3), Education (3), Pharmacy (3), Trade (domestic/foreign) (3), Defense (2), Banking (1), Budget/Appropriations (1), Disaster Planning/Emergencies (1), and 4 mores.
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICACopyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign), Pharmacy, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| NOVARTISCopyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues, Medicare/Medicaid | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BIOGEN, INC.Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code, Trade (domestic/foreign) | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| NATIONAL EMPLOYMENT OPPORTUNITIES NETWORKTaxation/Internal Revenue Code | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| NAPATREE TECHNOLOGY, LLCDefense | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| WAKE FOREST UNIVERSITYEducation | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLEducation | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| UNITED WAY WORLDWIDEHealth Issues, Housing, Disaster Planning/Emergencies | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| COALITION FOR SMARTER REGULATION OF NICOTINEHealth Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| DSRB DEVELOPMENT GROUPBanking | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| DUKE UNIVERSITYEducation, Taxation/Internal Revenue Code | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| PARTICULA GROUP INC.Financial Institutions/Investments/Securities | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)Medicare/Medicaid, Medical/Disease Research/Clinical Labs | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BIOTECHNOLOGY INNOVATION ORGANIZATIONMedical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| REGENXBIO INC.Health Issues, Medical/Disease Research/Clinical Labs | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| AVALYN PHARMA INC.Medical/Disease Research/Clinical Labs, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| CROWDSTRIKE, INC.Homeland Security | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| ATLANTIC COAST CONFERENCESports/Athletics | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.